Financial publications
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Press releases |
PDF
277.31 KB
|
PDF
609.93 KB
PDF
180.02 KB
|
PDF
441.51 KB
|
|
| Webcasts |
Video
|
|||
| Financial reports |
PDF
5.86 MB
|
|||
| Presentations |
PDF
2.58 MB
|
|||
| Transcripts |
PDF
171.84 KB
|
Agenda 2025
See allStart of the quiet period.
Full year 2024 results.
Start of the quiet period.
First-quarter results.
2024 Universal Registration Document.
Annual general meeting.
Start of the quiet period.
First-half results.
Start of the quiet period.
Third quarter results.
Latest financial press releases
See all
Oct 27th 2025
9M 2025 Results
Exosens achieves a strong 9M 2025 performance driven by continued defense tailwinds
Jul 30th 2025
H1 2025 Results
Exosens delivers strong H1 2025 performance in a highly-dynamic Defense market
May 26th 2025
Combined General Meeting 2025
Exosens combined general meeting of 23 may 2025 The meeting was attended by Mr Jérôme Cerisier, Chief Executive Officer, Ms Quynh-Boï Demey, Chief Financial Officer, Ms Bella Zisère, Human Resources Director, and the Company's Statutory Auditors.